B-cell lymphoma cell line derived from nodular lymphocyte predominance type of Hodgkin's lymphoma (NLPHL)

Cell Type:
Leukocyte (unspec.)
Tissue Origin:
lymph node
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
V A-023 3e6 33% 80% Plasmid (general) 5 µg 100 µl I/II/2b
V G-016 3e6 60% 70% Plasmid (general) 5 µg 100 µl I/II/2b
SG EO-100 5e5 50% 82% Plasmid (general) 400 ng 20 µl 4D X-Unit
SG DN-100 5e5 50% 78% Plasmid (general) 400 ng 20 µl 4D X-Unit